Correlation Between Artelo Biosciences and Synaptogenix

Can any of the company-specific risk be diversified away by investing in both Artelo Biosciences and Synaptogenix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Artelo Biosciences and Synaptogenix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Artelo Biosciences and Synaptogenix, you can compare the effects of market volatilities on Artelo Biosciences and Synaptogenix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Artelo Biosciences with a short position of Synaptogenix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Artelo Biosciences and Synaptogenix.

Diversification Opportunities for Artelo Biosciences and Synaptogenix

0.01

Correlation Coefficient

Artelo Biosciences  Synaptogenix

Significant diversification

The 3 months correlation between Artelo and Synaptogenix is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Artelo Biosciences and Synaptogenix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synaptogenix and Artelo Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Artelo Biosciences are associated (or correlated) with Synaptogenix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synaptogenix has no effect on the direction of Artelo Biosciences i.e., Artelo Biosciences and Synaptogenix go up and down completely randomly.

Pair Corralation between Artelo Biosciences and Synaptogenix

Assuming the 90 days horizon Artelo Biosciences is expected to generate 6.05 times more return on investment than Synaptogenix. However, Artelo Biosciences is 6.05 times more volatile than Synaptogenix. It trades about 0.03 of its potential returns per unit of risk. Synaptogenix is currently generating about 0.0 per unit of risk. If you would invest  3.80  in Artelo Biosciences on March 14, 2024 and sell it today you would lose (2.37) from holding Artelo Biosciences or give up 62.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	59.68%
Values	Daily Returns

Artelo Biosciences  vs.  Synaptogenix

Artelo Biosciences

Risk-Adjusted Performance

2 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Artelo Biosciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Artelo Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Synaptogenix

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Synaptogenix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Synaptogenix is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Artelo Biosciences and Synaptogenix

The main advantage of trading using opposite Artelo Biosciences and Synaptogenix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Artelo Biosciences position performs unexpectedly, Synaptogenix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synaptogenix will offset losses from the drop in Synaptogenix's long position.

The idea behind Artelo Biosciences and Synaptogenix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.